Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial
about
Recent advances in managing a spinal cord injury secondary to traumaThe Granulocyte-colony stimulating factor has a dual role in neuronal and vascular plasticityNeutrophil contribution to spinal cord injury and repair.A Systematic Review of Experimental Strategies Aimed at Improving Motor Function after Acute and Chronic Spinal Cord Injury.Concise Review: Bridging the Gap: Novel Neuroregenerative and Neuroprotective Strategies in Spinal Cord Injury.G-CSF as an adjunctive therapy with umbilical cord blood cell transplantation for traumatic brain injury.Traumatic Spinal Cord Injury-Repair and Regeneration.Assessment and management of acute spinal cord injury: From point of injury to rehabilitation.Traumatic spinal cord injury: current concepts and treatment update.Safety of granulocyte colony-stimulating factor (G-CSF) administration for postrehabilitated motor complete spinal cord injury patients: an open-label, phase I study.Case Report: Combination Therapy with Mesenchymal Stem Cells and Granulocyte-Colony Stimulating Factor in a Case of Spinal Cord Injury.Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury.Neuroprotective Effects of Direct Intrathecal Administration of Granulocyte Colony-Stimulating Factor in Rats with Spinal Cord Injury.Granulocyte Colony-Stimulating Factor Combined with Methylprednisolone Improves Functional Outcomes in Rats with Experimental Acute Spinal Cord Injury.Granulocyte Colony-Stimulating Factor Combined with Methylprednisolone Improves Functional Outcomes in Rats with Experimental Acute Spinal Cord Injury.Translational Advances in the Management of Acute Spinal Cord Injury: What is New? What is Hot?Study protocol for the G-SPIRIT trial: a randomised, placebo-controlled, double-blinded phase III trial of granulocyte colony-stimulating factor-mediated neuroprotection for acute spinal cord injury.Granulocyte-colony stimulating factor and umbilical cord blood cell transplantation: Synergistic therapies for the treatment of traumatic brain injuryLevel-Specific Differences in Systemic Expression of Pro- and Anti-Inflammatory Cytokines and Chemokines after Spinal Cord InjuryTraumatic spinal cord injury
P2860
Q26745909-678C43FD-5820-4F9D-A7E1-2A9AE375FA42Q26798071-BB711E63-BB5F-4D06-972A-EDE4AC468BBEQ34240286-BDB287AD-0438-478A-BAE0-00E7C8E3A4F7Q36654629-9D110123-4745-498C-AF68-FB0240AD7F12Q37042664-EE235982-1E57-4092-AD6A-5328137C8D41Q38342285-B8023D74-208B-4056-8552-13253C252749Q38738492-E269EB4A-B91B-4C22-9606-E3E1C5EBE0BAQ39344452-B87CC561-8465-4633-8339-F6D020268F5BQ39402793-03C5307B-DB50-4194-83EE-B2E1EACAB423Q40236265-8A603462-B191-4750-A4B1-F4530F97A3E2Q41789776-DEEB2B82-1191-474C-A0BB-B761AD156647Q47566621-1AA07961-D79A-4C13-A9EF-D3D8C0246464Q48077973-BBB3DDE3-C563-49CD-8836-DE351C7679C7Q49481278-258B6ACB-1372-4360-9F57-E28B67BB8382Q50024875-9725B7B3-A865-45E2-B52B-3C5B114E8751Q50130531-8DEC607E-F03C-46B6-822F-C7F793DE6C95Q53825391-8DA92784-70B1-46DC-BAB3-A6D29795B80DQ57153034-9E6792FB-AA01-4C3E-9DC1-275C2DF28B80Q57838197-08407CC9-8E3C-47A1-8C7B-25BBD9846A72Q57838429-8AAE7D98-1FA7-428F-8608-F89B8A90FD64
P2860
Neuroprotective therapy using granulocyte colony-stimulating factor for acute spinal cord injury: a phase I/IIa clinical trial
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Neuroprotective therapy using ...... : a phase I/IIa clinical trial
@ast
Neuroprotective therapy using ...... : a phase I/IIa clinical trial
@en
type
label
Neuroprotective therapy using ...... : a phase I/IIa clinical trial
@ast
Neuroprotective therapy using ...... : a phase I/IIa clinical trial
@en
prefLabel
Neuroprotective therapy using ...... : a phase I/IIa clinical trial
@ast
Neuroprotective therapy using ...... : a phase I/IIa clinical trial
@en
P2093
P2860
P1476
Neuroprotective therapy using ...... : a phase I/IIa clinical trial
@en
P2093
Akihiko Okawa
Chikato Mannoji
Hiroshi Takahashi
Junko Kawabe
Kazuhisa Takahashi
Koichi Hayashi
Masao Koda
Masashi Yamazaki
Masayuki Hashimoto
P2860
P2888
P304
P356
10.1007/S00586-012-2213-3
P577
2012-03-06T00:00:00Z